Company intelligence / Profile preview

TandemLife

Pittsburgh, Pennsylvania, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

CardiacAssist developed and commercialized the TandemHeart extracorporeal circulatory support system, which provides temporary mechanical circulatory assistance for critically ill cardiac patients. The system has been used in thousands of procedures at leading heart centers and demonstrated effective hemodynamic support with high flow rates. Clinical studies include use in acute myocardial infarction and as a bridge during high-risk interventions or surgeries. The LifeSPARC system was later introduced as an advanced pump/controller platform for extended duration use.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on TandemLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TandemLife.

Explore the full profile